Dynatrace
DT
$64.05
+1.07%
Dynatrace, Inc. is a software-as-a-service provider of observability and application performance monitoring, offering a unified platform that ingests and analyzes machine-generated telemetry — logs, metrics, traces, and topology data — across cloud, hybrid, and on-premise IT environments for enterprises seeking to optimize uptime and service-level objectives. The company is a recognized leader in the observability category, differentiated by its Grail data lakehouse architecture, automatic and causal AI (Davis), and a consolidated single-platform approach that positions it as a platform consolidator rather than a point-solution vendor, competing primarily against Datadog, Splunk (Cisco), New Relic, and Elastic. The current investor debate centers on whether Dynatrace's profitability and free-cash-flow discipline can offset a decelerating growth profile — guidance issued in May 2026 signaled a meaningful slowdown, and the stock was punished as the market rewarded faster-growing peers like Datadog — while bulls point to the August 2026 quarter's 16.2% YoY revenue growth reacceleration, expanding operating margins, and an aggressive buyback program as evidence the franchise remains intact. Sentiment has swung decisively positive since mid-2026, with the shares up roughly 29% over twelve months and multiple broker upgrades (Morgan Stanley to Overweight, Needham to Buy) reflecting renewed conviction that AI-driven observability demand and disciplined capital returns can support a re-rating.…
DT
Dynatrace
$64.05
Related headlines
Investment Opinion: Should I buy DT Today?
Rating: Hold with a constructive bias. The core thesis is that Dynatrace is a high-quality, cash-generative observability leader whose growth has stabilized at mid-teens, but the stock has already run 71.66% over six months and trades within 2.3% of the average analyst target of $62.53, leaving limited near-term upside. The consensus 'buy' rating (mean 1.70 across 34 analysts) and high target of $75 anchor a favorable long-term view, but the risk/reward at $61.11 is balanced rather than compelling.
Supporting evidence is strong: revenue grew 16.17% YoY to $554.5M, gross margin is 81.3%, operating margin expanded to 12.89% from 10.51% sequentially, TTM free cash flow is $568.1M with 98.97% conversion, and the balance sheet holds $1.058B cash against debt-to-equity of 0.063. The forward PE of 26.98x is reasonable for a 16% grower with 81% gross margins, and the PS of 5.45x is far below the 44.17x commanded in Q3 FY24, suggesting the de-rating has run its course. Analyst coverage is deep (34 analysts) with no recent downgrades and multiple upgrades (Morgan Stanley, Needham).
Risks that could invalidate the thesis: (1) growth decelerating back toward low-double digits, which would validate the May 2026 guidance-cut scenario and pressure the multiple; (2) competitive share loss to Datadog, whose accelerating growth has widened the valuation gap; and (3) the elevated 54.6% effective tax rate compressing net margins. This Hold would upgrade to Buy on a pullback toward the $57.50-$58.50 support shelf or a breakout above $66.30 on volume, and would downgrade to Sell if revenue growth decelerates below 12% or guidance is cut again. Valuation verdict: fairly valued relative to history and peers, with a slight discount to intrinsic value if mid-teens growth holds.
Sign up to view all
DT 12-Month Price Forecast
The forward view is balanced: the business is executing well with 16.17% revenue growth, 81.3% gross margins, and $568.1M TTM free cash flow, and the stock has de-rated massively from its historical multiples, leaving room to re-rate if growth holds. However, the stock has already run 71.66% over six months and sits within 2.3% of the average analyst target, so near-term upside is limited and mean-reversion risk is elevated after the -4.11% session on 6.78M shares. The base case (50% probability) sees consolidation toward $60-$66, with the bull case (30%) requiring a breakout above $66.30 and the bear case (20%) tied to a growth deceleration below 12%. I would upgrade to bullish on a confirmed breakout above $66.30 with raised guidance, and downgrade to bearish if revenue growth slips below 12% or another guidance cut materializes.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Dynatrace's 12-month outlook, with a consensus price target around $63.94 and implied upside of -0.2% versus the current price.
Average Target
$63.94
0 analysts
Implied Upside
-0.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$42 - $80
Analyst target range
Coverage is deep and overwhelmingly constructive: 34 analysts cover Dynatrace with a consensus recommendation of "buy" (mean rating 1.70 on a 1–5 scale, where 1 is Strong Buy), and the average target price of $62.53 implies roughly +2.3% upside from the current $61.11 — a modest gap that reflects how far the stock has already run toward consensus. The distribution skews bullish, and the recent tape of ratings actions confirms it: Morgan Stanley upgraded to Overweight from Equal Weight (Aug 25), Needham upgraded to Buy from Hold (Sep 18), and Oppenheimer, BMO, BTIG, Citigroup, Truist, Rosenblatt, and KeyBanc all reiterated Buy/Outperform/Overweight ratings through September — no downgrades appear in the recent record, signaling strengthening rather than deteriorating conviction.
The target range of $42.00 to $75.00 is wide — a 78.6% spread from low to high — indicating meaningful disagreement about the growth trajectory. The $75 high target implies roughly +22.7% upside and likely assumes reacceleration toward 18–20% growth, AI-observability share gains, and multiple expansion back toward 30x+ forward earnings; the $42 low target implies -31.3% downside and prices in a return to the May 2026 guidance-cut scenario — decelerating growth, competitive pressure from Datadog, and margin compression. With the average target ($62.53) barely above the current price and the stock trading at 84.9% of its 52-week range, the risk/reward is balanced: analysts see limited near-term upside to consensus, but the upgrade cycle and 34-analyst coverage suggest institutional support is strong, and a breakout above the $66.30 high would likely force target revisions higher.
Bulls vs Bears: DT Investment Factors
The bull case currently has stronger evidence: revenue reaccelerated to 16.17% YoY, FCF conversion is 98.97%, the balance sheet is net cash with debt-to-equity of 0.063, and analyst sentiment is uniformly constructive with no recent downgrades. However, the bear case is not without merit — trailing PE of 68.48x, EV/EBITDA of 31.1x, and only +2.3% upside to the average target mean the easy money has been made after a 71.66% six-month run. The single most important tension is whether mid-teens revenue growth is durable: if the August reacceleration holds and guidance is raised, the stock can re-rate toward the $75 high target; if growth slips back toward low-double digits, the May 2026 de-rating scenario returns and the $42 low target comes into play. The recent -4.11% session on 6.78M shares suggests profit-taking, but the uptrend structure (price at 84.9% of range, +10.73% over one month) remains intact.
Bullish
- Revenue reaccelerated to 16.2% YoY: Q1 FY27 revenue of $554.5M grew 16.17% YoY, accelerating from the prior quarter's $531.7M and defying the May 2026 guidance cut that had implied a slowdown. The sequential progression from $477.3M to $554.5M over five quarters shows uninterrupted expansion, supporting the thesis that the feared deceleration has not materialized.
- Best-in-class FCF and net cash balance sheet: TTM free cash flow of $568.1M with a 98.97% FCF conversion ratio (operating cash flow $306.2M vs. capex $3.15M in the latest quarter) funds $275.5M of buybacks and $99.5M of acquisitions without external financing. With $1.058B cash and debt-to-equity of just 0.063, the company is a self-funding compounder with minimal financial risk.
- Massive historical de-rating leaves room to re-rate: PS has compressed from 44.17x in Q3 FY24 to 5.45x today, and trailing PE from 97.7x to 68.5x, even as revenue grew. At 26.98x forward earnings on 16%+ growth and 81.3% gross margins, the stock trades at a discount to its own history and to faster-growing peers like Datadog, implying pessimistic expectations that could reverse if growth stabilizes.
- Analyst conviction strengthening, no downgrades: 34 analysts cover DT with a consensus 'buy' rating (mean 1.70) and an average target of $62.53, with a high target of $75 implying +22.7% upside. Morgan Stanley upgraded to Overweight (Aug 25) and Needham to Buy (Sep 18), and Oppenheimer, BMO, BTIG, Citigroup, Truist, Rosenblatt, and KeyBanc all reiterated Buy/Outperform through September with no downgrades in the recent record.
Bearish
- Growth deceleration remains the core risk: The May 2026 guidance cut signaled a significant slowdown and the stock plummeted on the news, with the market favoring Datadog's accelerating growth over Dynatrace's profitability. While the August quarter reaccelerated to 16.17%, the durability of mid-teens growth is unproven and any re-deceleration would validate the multiple compression.
- Valuation still rich on trailing metrics: Trailing PE of 68.48x, EV/EBITDA of 31.1x, and price-to-cash-flow of 19.67x are not cheap, and the trailing EPS of $0.0148 is distorted by a one-time tax benefit in the December 2024 quarter. The forward PE of 26.98x requires earnings to roughly 2.5x over twelve months, leaving little room for execution error.
- Tax rate distortion compresses net margin: A $44.15M tax expense on $80.80M pre-tax income (54.6% effective rate) compressed net margin to 6.61% from 14.57% pre-tax, and trailing net margin of 8.06% understates earnings power but also introduces earnings volatility. ROE of 6.23% and ROA of 4.17% look modest against a $6.6B+ equity base.
- Limited near-term upside to consensus: The average analyst target of $62.53 implies only +2.3% upside from $61.11, and the stock trades at 84.9% of its 52-week range, just 7.8% below the $66.30 high. With the stock up 71.66% over six months and 44.30% YTD, much of the recovery is priced in and mean-reversion risk is elevated.
DT Technical Analysis
Dynatrace is in a powerful, sustained uptrend: the stock has gained 29.01% over the past year, 44.30% year-to-date, and an extraordinary 71.66% over six months, decisively outperforming the S&P 500's 15.53% one-year and 11.93% YTD returns. At the current price of $61.11, the shares sit at approximately 84.9% of the 52-week range (low $31.635 to high $66.30), just 7.8% below the high — a positioning that signals strong momentum but also leaves limited near-term headroom before the stock tests prior resistance. The 52-week low of $31.635 implies the stock has nearly doubled off its trough, confirming a durable trend reversal rather than a dead-cat bounce, though the -36.49% max drawdown on record is a reminder of how violently this name can de-rate when growth expectations reset.
Short-term momentum is positive but decelerating at the margin: the stock is up 10.73% over the past month and 37.60% over three months, with relative strength versus SPY of +9.51 (1M), +34.91 (3M), and +64.18 (6M) — a pattern of persistent, widening outperformance. However, the most recent session saw a sharp -4.11% decline (from $63.73 to $61.11) on elevated volume of 6.78 million shares, and the stock has pulled back from its October 12 close of $65.25, suggesting profit-taking after a parabolic run from the August 4 level of $45.71 to the October high. This one-month strength (+10.73%) is consistent with, not divergent from, the one-year trend (+29.01%), so the recent dip reads as a healthy consolidation within an uptrend rather than a reversal signal, though the velocity of the move raises mean-reversion risk.
Key technical levels are well defined: immediate support sits at the $57.50–$58.50 shelf (late-September consolidation) with deeper support at the 52-week low of $31.635, while resistance is the 52-week high of $66.30, only ~8.5% above the current price. A breakout above $66.30 on volume would confirm the multi-month uptrend and likely open a new leg higher, whereas a breakdown below $57.50 would signal the August–October advance is exhausting and put the $50–$52 zone in play. With a beta of 0.769, Dynatrace is roughly 23% less volatile than the broad market — unusual for a high-multiple software name — which supports larger position sizing on a risk-adjusted basis, though the stock's own -36.49% max drawdown and 2.14 short ratio indicate that idiosyncratic event risk (earnings, guidance) can overwhelm the low beta.
Beta
0.77
0.77x market volatility
Max Drawdown
-36.5%
Largest decline past year
52-Week Range
$32-$66
Price range past year
Annual Return
+28.3%
Cumulative gain past year
| Period | DT Return | S&P 500 |
|---|---|---|
| 1m | +9.5% | -1.0% |
| 3m | +53.9% | +2.9% |
| 6m | +81.5% | +6.5% |
| 1y | +28.3% | +13.1% |
| ytd | +51.2% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
DT Fundamental Analysis
Revenue is growing at a healthy but moderating pace: the most recent quarter (ended June 30, 2026) delivered $554.5 million in revenue, up 16.17% year-over-year, accelerating from the prior quarter's $531.7 million (Q4 FY26) and $515.5 million (Q3 FY26), which grew off a $477.3 million base in the year-ago Q1. The sequential progression from $477.3M → $493.8M → $515.5M → $531.7M → $554.5M shows steady, uninterrupted expansion, and the subscription segment dominates the mix at $530.3 million versus just $24.3 million in services — a ~95.6% recurring-revenue model with high visibility. The key debate is durability: the May 2026 guidance cut implied deceleration, but the August print's 16.2% growth and consensus FY revenue estimate of $3.625 billion suggest the feared slowdown has not materialized, supporting the investment case for a durable mid-teens grower with best-in-class retention.
Profitability is solid and improving: Q1 FY27 net income was $36.65 million (6.61% net margin) on $451.1 million of gross profit, a gross margin of 81.34% — consistent with the 80.9%–82.1% band maintained over the past eight quarters, reflecting the economics of a mature software platform. Operating income of $71.48 million (12.89% operating margin) expanded from $55.87 million (10.51%) in the prior quarter and $62.34 million (13.06%) a year ago, while EBITDA of $69.81 million (12.59% margin) compares to $52.98 million (9.96%) sequentially — evidence of operating leverage as R&D ($136.0M) and S&M ($181.6M) grow slower than revenue. The one blemish is tax: a $44.15 million tax expense on $80.80 million pre-tax income (54.6% effective rate) compressed net margin to 6.61% from 14.57% pre-tax, a timing/valuation-allowance artifact rather than an operating deterioration, and trailing net margin of 8.06% understates underlying earnings power.
Financial health is exceptional: debt-to-equity is just 0.063, the current ratio is 1.35, and the company holds $1.058 billion in cash against negligible debt, giving it ample liquidity. Free cash flow is the standout — $568.1 million TTM, with $303.1 million generated in the most recent quarter alone (operating cash flow of $306.2 million against just $3.15 million of capex, a 98.97% FCF conversion ratio) — funding $275.5 million of buybacks in the quarter and $99.5 million of acquisitions without external financing. ROE of 6.23% and ROA of 4.17% look modest only because of a $6.6 billion-plus equity base inflated by IPO proceeds and buybacks; on a cash-flow basis, the business is a self-funding compounder, and the 19.67x price-to-cash-flow multiple reflects that quality rather than leverage-driven risk.
Quarterly Revenue
$554548000.0B
2026-06
Revenue YoY Growth
+16.2%
YoY Comparison
Gross Margin
81.3%
Latest Quarter
Free Cash Flow
$568122000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is DT Overvalued?
Because Dynatrace is profitable (net income of $36.65 million in the latest quarter and positive TTM earnings), the PE ratio is the appropriate primary metric: the trailing PE is 68.48x versus a forward PE of 26.98x, a dramatic 61% compression that implies the market expects earnings to roughly 2.5x over the next twelve months — consistent with consensus EPS of $3.07 versus trailing EPS of $0.0148 (the trailing figure is distorted by a one-time tax benefit in the December 2024 quarter that inflated reported earnings and by the elevated current tax rate). The forward multiple is the more meaningful anchor, and at 26.98x forward earnings the stock is priced for solid but not heroic growth, leaving room for multiple expansion if the 16%+ revenue trajectory holds.
On peer comparison, the picture is mixed: the PS ratio of 5.45x and EV/Sales of 8.34x are far below the 20x–45x sales multiples Dynatrace itself commanded in 2021–2023 and below high-growth observability peers like Datadog, reflecting the market's preference for faster growth. Against the broader application-software sector, a 5.45x PS on 16% growth (roughly 0.34x growth-adjusted) and a 26.98x forward PE are reasonable-to-attractive for an 81% gross-margin, 13% operating-margin franchise — the discount appears to price in deceleration fears rather than any fundamental impairment, and the 31.1x EV/EBITDA is moderate for a software leader with 99% FCF conversion.
Historically, Dynatrace's valuation sits near the low end of its own range: the PS ratio has compressed from 44.17x (Q3 FY24), 38.12x (Q2 FY25), and 34.72x (Q1 FY26) to 5.45x today, while the PE has fallen from 97.7x (Q3 FY24) and 86.3x (Q1 FY26) to 68.5x trailing / 27.0x forward. This is a stock that has de-rated massively even as the business grew — the classic "multiple compression offsetting earnings growth" pattern — which means the current price embeds pessimistic expectations; if growth stabilizes in the mid-to-high teens, the historical band argues for re-rating potential, whereas a further leg down in growth would validate the compression.
PE
68.5x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 11x~302x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
31.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are modest but not negligible. The company carries debt-to-equity of only 0.063 and $1.058B in cash, so leverage is not a concern; however, the 54.6% effective tax rate in Q1 FY27 ($44.15M tax on $80.80M pre-tax) compressed net margin to 6.61% and introduces earnings volatility that could persist if valuation allowances recur. Revenue concentration in subscription ($530.3M of $554.5M, ~95.6%) is a strength for visibility but means any churn or seat contraction in the observability platform flows directly to the top line, and the 16.17% growth rate leaves little buffer if enterprise IT budgets tighten. Free cash flow of $568.1M TTM is robust, but the $275.5M quarterly buyback pace and $99.5M of acquisitions depend on continued cash generation; a growth stall would force a choice between capital returns and reinvestment.
Market and competitive risks center on valuation compression and the Datadog gap. At 68.48x trailing PE, 31.1x EV/EBITDA, and 5.45x PS, the stock is not cheap on trailing metrics, and the forward PE of 26.98x assumes earnings roughly 2.5x over twelve months — a miss would hit the multiple hard. The May 2026 guidance cut and the 'Datadog Soars, Dynatrace Slumps' narrative show how quickly sentiment can turn when growth decelerates relative to peers, and the 'SaaS apocalypse' buyback narrative (Feb 2026) highlights sector-wide AI disruption fears. Beta of 0.769 suggests ~23% less volatility than the market, but the -36.49% max drawdown and 2.14 short ratio show idiosyncratic event risk (earnings, guidance) can overwhelm the low beta, and persistent wholesale inflation pricing out Fed rate cuts pressures high-multiple software multiples.
Worst-case scenario: a return to the May 2026 guidance-cut playbook — growth decelerating below 12%, Datadog continuing to take share, and the market re-rating the stock back toward the $42 analyst low target. From $61.11, that implies roughly -31.3% downside, and a full retest of the 52-week low of $31.635 would imply -48.2%. The stock has already shown it can de-rate violently (max drawdown -36.49%), so an investor could realistically lose 30-48% in an adverse scenario, with the $57.50-$58.50 support shelf the first line of defense and a break below it putting the $50-$52 zone in play.
FAQ
Ranked by severity: (1) Growth deceleration — the May 2026 guidance cut showed how quickly sentiment turns, and a slip below 12% growth would validate the de-rating and pressure the stock toward the $42 low target; (2) Competitive pressure from Datadog, whose accelerating growth has widened the valuation gap and could drive share loss in AI observability; (3) Valuation compression — at 68.48x trailing PE and 31.1x EV/EBITDA, a miss against the 26.98x forward PE assumption of 2.5x earnings growth would hit the multiple hard, especially with persistent inflation pricing out Fed rate cuts; and (4) Earnings volatility from the 54.6% effective tax rate, which compressed net margin to 6.61% in Q1 FY27 and could distort comparisons.
The 12-month forecast has three scenarios: bull case (30% probability, $70-$75) requiring high-teens growth, AI observability share gains, and a breakout above $66.30; base case (50% probability, $60-$66) assuming mid-teens growth and consolidation near the $62.53 average analyst target; and bear case (20% probability, $42-$50) tied to growth decelerating below 12% and a repeat of the May 2026 guidance-cut scenario. The base case is most likely, with the key assumption being that revenue growth of 15-17% is sustained through FY27 and operating margins hold above 12.5%. The wide $42-$75 analyst target range (78.6% spread) reflects genuine disagreement about the growth trajectory.
DT appears fairly valued to slightly undervalued relative to its own history and peers. The trailing PE of 68.48x looks rich, but the forward PE of 26.98x is reasonable for a company growing 16.17% with 81.3% gross margins, and the PS of 5.45x is far below the 44.17x commanded in Q3 FY24 and the 34.72x in Q1 FY26. EV/EBITDA of 31.1x and price-to-cash-flow of 19.67x are moderate for a software leader with 98.97% FCF conversion. The market is paying a fair price that embeds pessimistic growth expectations — if mid-teens growth holds, the historical band argues for re-rating potential toward 30x+ forward earnings, but a further growth deceleration would validate the compression.
From a risk/reward perspective, DT is a reasonable but not compelling buy at $61.11: the average analyst target of $62.53 implies only +2.3% upside, while the high target of $75 offers +22.7% and the low target of $42 implies -31.3% downside. The business fundamentals are strong — 16.17% revenue growth, 81.3% gross margins, $568.1M TTM free cash flow, and debt-to-equity of 0.063 — and the forward PE of 26.98x is reasonable for a 16% grower. However, the stock has already gained 71.66% over six months and trades at 84.9% of its 52-week range, so much of the recovery is priced in. It is a good buy for long-term investors on a pullback toward the $57.50-$58.50 support shelf, or on a confirmed breakout above $66.30, but chasing at current levels carries mean-reversion risk.
DT is better suited for long-term holding with a minimum suggested period of 2-3 years. The company is a mature growth-stage SaaS provider with 16.17% revenue growth, 95.6% recurring subscription revenue, and no dividend (payout ratio 0%, dividend yield 0%), so returns depend on earnings growth and multiple re-rating rather than income. Beta of 0.769 suggests lower market volatility, but the -36.49% max drawdown and 2.14 short ratio show event risk around earnings and guidance can be severe, making short-term trading risky. Earnings visibility is high given the recurring model and $1.058B cash balance, supporting a patient holding period through the current consolidation.